Please login to the form below

I have forgotten my password

Webinars

Beyond the Blame Game: Improving Patient, Physician, Pharma Relations
Wednesday, 7 November 2018 - 3:00 pm
We often hear patients report a lack of ‘connection’ with their physician, and where lifestyle plays a role in the development of a disease, such as obesity or type 2 diabetes, patients may even feel the doctor blames them for their condition.

Andrew McConaghie, Group Editor

FREE | VIEW NOW
Transforming Access to Medicines Through Patient-Centric Solutions
Thursday, 14 December 2017 - 2:00 pm
As medicines access evolves and pharmaceutical companies take an increasingly nuanced approach to it, it’s ever-more important to focus on particular aspects of this area and investigate whether firms are operating optimally.

Dominic Tyer, Editorial director

FREE | VIEW NOW
The Future of Marketing in Life Sciences: Is your function fit for purpose
Thursday, 30 November 2017 - 2:00 pm
The healthcare landscape is rapidly changing as it responds to a multitude of well-known issues. Coupled with emerging digital technologies, these drivers are shaping the industry, moving it towards a more sophisticated, outcomes-driven model that demands a new approach.

Dominic Tyer, Editorial director

FREE | VIEW NOW
The Power of Storytelling in Health: Friend or Foe?
Wednesday, 15 November 2017 - 3:00 pm
With traditional media moving online, and the era of social media driving stories through the ethernet, never has a ‘story’ been more impactful.

Dominic Tyer, Editorial director

FREE | VIEW NOW
The Truth about Doctors
Thursday, 19 October 2017 - 3:00 pm
‘The Truth about Doctors’ the first study in the series, aims to get to the heart of the human under the white coat to better understand what motivates doctors and how we can improve the way we communicate to them.

Dominic Tyer, Editorial director

FREE | VIEW NOW
Proving the Strategic Value of Patients
Tuesday, 10 October 2017 - 3:00 pm
Patient insights aren’t just a ‘nice to have’: they are essential to understand the space where Pharma’s drugs ‘live’.

Dominic Tyer, Editorial director

FREE | VIEW NOW
Regret Minimisation
Tuesday, 11 July 2017 - 3:00 pm
When new products approach the market the level of demand for them is often exaggerated.

Dominic Tyer, Editorial director

FREE | VIEW NOW
Assessing early market opportunity
Wednesday, 19 April 2017 - 3:00 pm
To successfully develop and launch an asset it’s crucial to identify and define the commercial value early in the process.

Dominic Tyer, Editorial director

FREE | VIEW NOW
PC: Are you Patient Centric or just Politically Correct?
Tuesday, 24 January 2017 - 3:00 pm
Everyone in pharma is talking about patient centricity, but how is the drive received ‘on the ground’ among patients who are its focus? How is it unfolding and how far is it being implemented? Do patients even notice it is happening?

Dominic Tyer, Editorial director

FREE | VIEW NOW
Communicating innovation to payers and policy makers
Monday, 28 November 2016 - 3:00 pm
Involving public affairs early during the development and commercialisation process of a new asset is critical to success when demonstrating value to payers and policy makers.

Dominic Tyer, Editorial director

FREE | VIEW NOW
Immuno-oncology's evolution: implications for pharma market researche
Thursday, 17 November 2016 - 3:00 pm
Immuno-oncology therapies that harness the body’s own defences to fight tumours are widely acknowledged as the new frontier in cancer treatment, but until recently only a few products had reached the market for a limited number of indications.

Dominic Tyer, Editorial director

FREE | VIEW NOW
Scale & Strategy: Essential tools for transforming the commercial model
Wednesday, 9 November 2016 - 2:00 pm
Most life sciences companies know they need to move their multichannel marketing forward, but that requires managing a greater volume of tactics that need to be developed, approved, implemented, and measured.

Dominic Tyer, Editorial director

FREE | VIEW NOW
Driving adoption of Commercial Analytic solutions
Tuesday, 25 October 2016 - 3:00 pm
Measuring campaign success is key for pharma and the rise of multichannel campaigns has brought with it an increase in spending on commercial analytic solutions, which help users identify opportunities for improvements.

Dominic Tyer, Editorial director

FREE | VIEW NOW
Modelling ‘smart’ and ‘lazy’ thinking to influence decision-making
Tuesday, 4 October 2016 - 3:00 pm
Traditional models of cognitive behaviour remain meaningful, but they can fail to deliver strong links between ‘smart’, cognitive-based factors of judgement and the decision-making associated with actual behaviour change.

Dominic Tyer, Editorial director

FREE | VIEW NOW
Strengthening market access deliverables by harnessing the patient journey
Wednesday, 14 September 2016 - 3:00 pm
In today’s multi-stakeholder environment, pharma companies need to coordinate their stakeholder interactions between functions to ensure consistency of message and efficiency of cost.

Dominic Tyer, Editorial director

FREE | VIEW NOW
The value of early asset development and commercialisation
Wednesday, 13 July 2016 - 3:00 pm
Linking the clinical benefit of a product to a real-world benefit that markets care about, insurers will pay for and that will improve patients’ lives is critical for pipeline assets to succeed.

Dominic Tyer, Editorial director

FREE | VIEW NOW
Developing medical education that advances patient outcomes
Thursday, 30 June 2016 - 2:00 pm
As pressure mounts on the pharmaceutical industry to demonstrate a tangible and positive impact on patients’ lives, understanding barriers to specific clinician behaviours is key to achieving measurable change in clinical practice and advancing patient outcomes.

Dominic Tyer, Editorial director

FREE | VIEW NOW
Customer engagement design in pharma
Thursday, 19 May 2016 - 3:00 pm
In recent years pharma has slowly been realising the importance of customer experience and the fact that the commercial model that served it so well for the past 30 years might not be the right one for the future.

Dominic Tyer, Editorial director

FREE | VIEW NOW
Rare diseases: Regulatory and reimbursement submissions, the challenges
Tuesday, 22 March 2016 - 3:00 pm
Companies developing rare disease treatments face several unique challenges when it comes to regulatory and reimbursement submissions.

Dominic Tyer, Editorial director

FREE | VIEW NOW
Meaningful digital initiatives need face time
Wednesday, 10 February 2016 - 3:00 pm
Doctors are increasingly using social media and other online channels to search for and share information, but face-to-face interactions still carry more trust and are more likely to influence prescribing.

Dominic Tyer, Editorial director

FREE | VIEW NOW